Author:
Gessner Bradford D.,Jiang Qin,Van Werkhoven Cornelis H.,Sings Heather L.,Webber Chris,Scott Daniel,Gruber William C.,Grobbee Diederick E.,Bonten Marc J.M.,Jodar Luis
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference23 articles.
1. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults;Bonten;N Engl J Med,2015
2. Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia;Huijts;Eur Respir J,2013
3. Final Report: A phase 4, randomized, placebo-controlled clinical trial of 13-valent pneumococcal conjugate vaccine efficacy in prevention of vaccine-serotype pneumococcal community-acquired pneumonia and invasive pneumococcal disease. Clinical Study Report, Protocol 6115A1-3006 (B1851025). Pfizer Vaccine Research & Development. May 22, 2014.
4. Prevnar 13, request of 18 Dec 2014, response to FDA. STN 125324/1196. Pfizer Vaccines. January 2015.
5. Pneumococcal community-acquired pneumonia detected by serotype-specific urinary antigen detection assays;Wunderink;Clin Infect Dis,2018
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献